Colorado BioScience Association Appoints Four Industry Leaders to Board of Directors

DENVER--()--The Colorado BioScience Association (CBSA) appointed four new board members at its 2012 Annual All-Member Meeting held at the Westin Westminster, Westminster, CO, yesterday. The announcement is made jointly by Steve Orndorff, Ph.D., Chairperson of the Board of Directors and Holli Riebel, CBSA President & CEO of CBSA.

Newly appointed CBSA board members include:

  • James Chomas, Ph.D., Founder & CEO, Surefire Medical - Westminster -
  • Scott Deeter, President & CEO, Ventria Bioscience - Fort Collins -
  • Brent Fassett, Partner, Cooley LLP - Broomfield -
  • Kerry Ingalls, Vice President of Colorado Operations, Amgen - Boulder/Longmont -

Riebel says: "CBSA’s board is a prestigious group of industry leaders comprised of representatives of biotechnology, medical device, diagnostic, pharmaceutical, health care providers, research institutions and those businesses that provide critical services and products to bioscience companies. Board members commit to a three-year term to support CBSA’s mission to support the regional bioscience community through advocacy, resources and advancement of opportunities for collaboration. CBSA board members work in partnership with staff to support the drive and determination of over 600 Colorado bioscience companies that work to improve lives locally and around the world."

“On behalf of the Board of Directors, I would like to thank the retiring eleven directors for their service and welcome the four new appointees,” Orndorff stated. Special recognition was given to Norwood Robb for serving on the board for ten years. The Executive Officers , in addition to Orndorff, is now instated as Derek Cole, Board Vice Chair, Vice President, Investor Relations & Corporate Communications, ARCA Biopharma; Jim Wilson, Board Treasurer, Senior Audit Manager, Ernst & Young; and John Dunning, Board Secretary, President & CEO, Clarimedix Inc.

Reappointments of CBSA board members include:

  • Lisa Drake, Director Government Affairs, Monsanto -
  • Dick Hinson, Senior Vice President, Aurora Economic Development Council -
  • Rick Jory, President and CEO, Sandhill Scientific, Inc - (Past Board Chair)
  • Mark Lupa, Partner, High Country Venture -
  • Steve Orndorff, President and CEO, Ariel Pharmaceuticals - (Board Chair)
  • Mark Spiecker, Chief Executive Officer, Sharklet Technologies - (Education Committee Chair)
  • Dan Wittenberg, Partner, Snell & Wilmer LLP - (Public Policy Committee Chair)

Link to the CBSA 2012 Board Member profiles:

The CBSA’s 2012 association sponsors include:

Titanium –


Boettcher Foundation -

Colorado Science + Technology Park at Fitzsimons -

Colorado State University -

Dorsey & Whitney -

Fisher Scientific -

Platinum –

Colorado Office of Economic Development and International Trade -

University of Colorado -

Cooley -

Ernst & Young -


Gold –

Amgen -

LABS Inc. -

Merck -

Snell & Wilmer -

Silver –

Colorado Small Business Development Center -

Faegre Baker Daniels LLP -

Metro Denver Economic Development Corporation -

Pfizer -

Polsinelli Shughart -

Sheridan Ross -

Southeast Business Partnership -

TerumoBCT -

Bronze –

Baxa -

EideBailly -


GlaxoSmithKline -

Genentech -

Johnson & Johnson -

Roche Custom Biotech -

SomaLogic -


The Wright Group/Travelers - /

About Colorado BioScience Association

The CBSA is a not-for-profit organization providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on behalf of the industry. For more information, visit

CBSA also is found on these social media sites:

LinkedIn Group:
Facebook Fan Page:
News Feed:
YouTube Channel:


Colorado BioScience Association
Mae Desaire, 720-382-5918
Director of Marketing
Absolutely Public Relations
Maggie Chamberlin Holben, 303-984-9801

Release Summary

Four industry executives were named to the Colorado BioScience Association (CBSA) Board of Directors at its 2012 Annual All-Member Meeting.


Colorado BioScience Association
Mae Desaire, 720-382-5918
Director of Marketing
Absolutely Public Relations
Maggie Chamberlin Holben, 303-984-9801